Filing Flows › Comparisons › CRVO vs BOLT
CervoMed vs Bolt Biotherapeutics: CRVO and BOLT compared
CervoMed is the larger company: $9K of revenue in its latest quarter (Q4 2025) against $5K for Bolt Biotherapeutics (Q2 2026). CervoMed is growing faster (-100% against -100% a year earlier).
Where the money goes: CRVO and BOLT
CervoMed (CRVO) · Q4 2025
CervoMed, Q4 2025: revenue $9K (-100% year over year), net loss $8.1M, operating cash flow −$6.6M. The chart follows the revenue to costs, profit and cash.
Bolt Biotherapeutics (BOLT) · Q2 2026
Bolt Biotherapeutics, Q2 2026: revenue $5K (-100% year over year), net loss $7.7M, operating cash flow −$6.5M. The chart follows the revenue to costs, profit and cash.
| CervoMed (CRVO) | Bolt Biotherapeutics (BOLT) | |
|---|---|---|
| Latest quarter | Q4 2025 | Q2 2026 |
| Revenue | $9K | $5K |
| Revenue growth, Y/Y | -100% | -100% |
| Operating margin | n/m | n/m |
| Net earnings | −$8.1M | −$7.7M |
| Operating cash flow | −$6.6M | −$6.5M |
Questions
Which is bigger, CervoMed or Bolt Biotherapeutics?
CervoMed is the larger company: $9K of revenue in its latest quarter (Q4 2025) against $5K for Bolt Biotherapeutics (Q2 2026).
Is CervoMed or Bolt Biotherapeutics growing faster?
CervoMed is growing faster (-100% against -100% a year earlier).
More: CervoMed earnings · how CervoMed makes money · Bolt Biotherapeutics earnings · how Bolt Biotherapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-K filed Mar 13, 2026; 10-Q filed Aug 11, 2026). Fiscal quarters can end on different dates. Not investment advice.